Jounce Therapeutics Inc. (JNCE) gained 5.23% or 0.38 to $7.65. It is approximately 297030 shares traded, which is 24.52% compare to the average total volume 1.21 million. The market cap of JNCE is $248.50 million. The year to date change is 476.95%. The 52 week price range is from $6.92 to $29.25. Price of JNCE have changed -4.59% during last week. It have changed -56.67% over last month, -73.08% over last 3 months, -50.24% over last 6 months and -54.76% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 16.24. It is 112.29% above current price. The 200-day Moving Averages for JNCE is 17.45. It is 128.10% above current price. The 52-week High is 29.25. It is 282.35% from the current price. The 52-week Low is 6.92. It is -9.54% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of JNCE is 11.95 on 2018-05-15. Short % to float is 13.53%. There are some statistics of JNCE. It is has market cap $248.50 million. The share outstanding is 32.48 million. The average volume is 1.21 million. The revenue is 38.37M. The percent of top 15 Institution holding is 45.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -18.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -8.61%.